Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Total Non-Current Liabilities (2016 - 2025)

Mimedx (MDXG) has disclosed Total Non-Current Liabilities for 15 consecutive years, with $80.7 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 27.29% to $80.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $80.7 million through Dec 2025, up 27.29% year-over-year, with the annual reading at $80.7 million for FY2025, 27.29% up from the prior year.
  • Total Non-Current Liabilities hit $80.7 million in Q4 2025 for Mimedx, up from $74.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $103.2 million in Q1 2021 to a low of $58.3 million in Q2 2024.
  • Historically, Total Non-Current Liabilities has averaged $81.7 million across 5 years, with a median of $87.5 million in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: crashed 37.55% in 2024 and later rose 27.29% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $90.5 million in 2021, then increased by 1.84% to $92.2 million in 2022, then rose by 2.12% to $94.1 million in 2023, then plummeted by 32.6% to $63.4 million in 2024, then increased by 27.29% to $80.7 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for MDXG at $80.7 million in Q4 2025, $74.5 million in Q3 2025, and $67.5 million in Q2 2025.